DelveInsight has launched a new report on Prostate Cancer Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s “Prostate cancer – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Prostate cancer, historical and forecasted epidemiology as well as the Prostate cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Prostate cancer market report provides current treatment practices, emerging drugs, Prostate cancer market share of the individual therapies, current and forecasted Prostate cancer market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Prostate cancer treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Prostate cancer begins when cells in the prostate gland—only found in males—start to grow uncontrollably. Prostate cancer affects the gland that nourishes and propels semenand plays a role in urine control in men.
Request for :- Prostate Cancer free sample page
The Prostate cancer epidemiology division provide insights about historical and current Prostate cancer patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Report Key facts:-
1. According to theNational Cancer Institute, approximately 10–20% of prostate cancer cases are castration-resistant, and up to 16% of these patients show no evidence thatcancer has spread at the time of the castration-resistant diagnosis.
2. According to the Prostate Cancer UK, over 47,500 men are diagnosed with prostate cancer every year—i.e. 129 men every day. One in eight men will be diagnosed with prostate cancer in their lifetime.
3. According to the Global Cancer Observatory, in 2018, there were 70,654; 212,783; 62,641; 64955; 43,837; 31,728; 56,401 new cases of prostate cancer reported in Japan, the United States, Germany, France, Italy, Spain, and the UK, respectively.
1. Key Insights
2. Executive Summary of Prostate cancer
3. Competitive Intelligence Analysis for Prostate cancer
4. Prostate cancer: Market Overview at a Glance
4.1. Prostate cancer Total Market Share (%) Distribution in 2017
4.2. Prostate cancer Total Market Share (%) Distribution in 2030
5. Prostate cancer: Disease Background and Overview
6. Patient Journey
7. Prostate cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Prostate cancer Treatment
11. Marketed Products
12. Emerging Therapies
13. Prostate cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Prostate cancer
17. KOL Views
18. Market Drivers
19. Market Barriers
20.2. Report Methodology
21. DelveInsight Capabilities
23. About DelveInsight
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Prostate cancer market
- To understand the future market competition in the Prostate cancer market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Prostate cancer in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Prostate cancer market
- To understand the future market competition in the Prostate cancer market
Related Reports :-
Company Name: DelveInsight Business Research LLP
Contact Person: Priya Maurya
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States